The Growing Crisis of Cancer Drug Shortages in the US.

Widespread shortages of cancer drugs are forcing doctors to make difficult decisions about how to treat their patients, including rationing doses and turning to other treatment options with potentially more side effects. As of Wednesday, the Food and Drug Administration listed 14 cancer drugs in shortage. The current carboplatin shortage was caused in part by quality concerns at one manufacturing facility, Intas Pharmaceuticals, in India, but experts say the real problem is more chronic. Long-term solutions are going to require “intervention by Congress and the White House in order to get this industry in the right place,” said FDA Commissioner Dr. Robert Califf.